Uptravi Approved for Chronic Lung Disease

TUESDAY, Dec. 22, 2015 — Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a disabling lung disease that often leads to death or the need for lung transplant.
PAH is…
Source: Topamax